Business Tilray Q3 revenue dips 2% to US$151.9M The company says it has a 20% market share in Germany with its whole flower, extracts and Dronabinol products Natalia Buendia CalvilloApril 7, 2022
Business Hexo defaults on senior debt, but lender waives event due to Tilray deal The firm could've been immediately on the hook to pay 115% of the principal owed Nick LabaMarch 14, 2022
Business Tilray medical cannabis products now available at pharmacies in Malta In December, the country became the first to legalize recreational pot in the EU Natalia Buendia CalvilloFebruary 17, 2022
Business MedMen’s chief revenue officer resigns No explanation has yet been given for the move Nick LabaFebruary 14, 2022
Business Tilray re-brands therapeutic divisions as Tilray Medical The firm says Canadian patients will get broader access to its products, as it continues to push for international growth Natalia Buendia CalvilloFebruary 8, 2022
Business Tilray launches new medical products and training program in Australia The company says it's using learnings from operations in Germany to better meet patient needs Nick LabaJanuary 25, 2022
Business Tilray ekes out Q2 profit despite 16% drop in pot sales For better or for worse, the firm's focus appears to be moving further away from cannabis sales Nick LabaJanuary 10, 2022